ImmunityBio's market cap is currently $2.45B. The company's EPS TTM is $-0.886; its P/E ratio is ―; ImmunityBio is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 622.00K	$ 240.00K	$ 934.00K	$ 605.00K	$ 2.20M
Gross Profit	$ 622.00K	$ -23.95M	$ 934.00K	$ -8.54M	$ -6.81M
Operating Income	$ -362.25M	$ -351.30M	$ -330.28M	$ -220.88M	$ -156.25M
EBITDA	$ -436.18M	$ -335.51M	$ -315.38M	$ -187.93M	$ -142.27M
Net Income	$ -583.20M	$ -417.32M	$ -349.85M	$ -224.19M	$ -160.16M
Balance Sheet
Cash & Short-Term Investments	$ 266.46M	$ 107.18M	$ 317.12M	$ 96.06M	$ 51.65M
Total Assets	$ 504.45M	$ 362.36M	$ 468.91M	$ 221.38M	$ 143.12M
Total Debt	$ 726.72M	$ 723.77M	$ 645.66M	$ 275.55M	$ 14.85M
Net Debt	$ 461.27M	$ 619.13M	$ 464.56M	$ 240.63M	$ -660.00K
Total Liabilities	$ 1.09B	$ 812.18M	$ 712.82M	$ 339.87M	$ 22.44M
Stockholders' Equity	$ -586.99M	$ -447.33M	$ -242.17M	$ -119.81M	$ 120.68M
Cash Flow
Free Cash Flow	$ -397.34M	$ -436.90M	$ -307.98M	$ -173.39M	$ -156.40M
Operating Cash Flow	$ -366.76M	$ -337.51M	$ -274.42M	$ -171.72M	$ -152.11M
Investing Cash Flow	$ -30.47M	$ 27.30M	$ -84.89M	$ -19.81M	$ 18.55M
Financing Cash Flow	$ 558.34M	$ 233.61M	$ 505.44M	$ 150.68M	$ 114.28M

Currency in USD

ImmunityBio Earnings and Revenue History

Income Statement >

ImmunityBio Debt to Assets

Balance Sheet >

ImmunityBio Cash Flow

Cash Flow >

ImmunityBio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing